Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study. 1987

J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
Service de Médecine Nucléaire et Ultra-Sons, Hôpital Bretonneau, Tours, France.

Fifty meta-iodobenzylguanidine (MIBG) scintiscans were performed in three groups of medullary thyroid cancer (MTC) patients. Group 1 (n = 11) included treated patients with normal calcitonin levels; Group 2 (n = 24) included patients with elevated calcitonin levels due to sporadic and isolated MTC; Group 3 (n = 15) included patients with elevated calcitonin levels due to familial MTC or multiple endocrine neoplasia Type IIA syndrome (MEN). In Group 1 three pheochromocytoma were depicted by MIBG scintiscan. In Group 2 MTC was seen in a small number of patients (3 of 24). In Group 3, besides adrenal hyperplasia and pheochromocytoma four patients, MIBG scintigraphy showed where MTC had localized and spread in almost half of patients (7 of 15). MIBG uptake occurred in patients with relatively high calcitonin level (greater than 0.6 nmol/l). These data indicate that in patients with familial MTC or MEN syndrome, MIBG scintiscan can be useful not only in detecting associated pheochromocytoma, but also in showing MTC.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007462 Iodobenzenes Any derivative of BENZENE that contains IODINE.
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009377 Multiple Endocrine Neoplasia A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively. Adenomatosis, Familial Endocrine,Endocrine Neoplasia, Multiple,Multiple Endocrine Neoplasia Syndrome,Neoplasia, Multiple Endocrine,Neoplasms, Multiple Endocrine,Adenomatosis, Multiple Endocrine,Familial Endocrine Adenomatosis,Multiple Endocrine Adenomatosis,Multiple Endocrine Adenopathy,Multiple Endocrine Neoplasia Syndromes,Multiple Endocrine Neoplasms,Adenomatoses, Familial Endocrine,Adenomatoses, Multiple Endocrine,Adenopathies, Multiple Endocrine,Adenopathy, Multiple Endocrine,Endocrine Adenomatoses, Familial,Endocrine Adenomatoses, Multiple,Endocrine Adenomatosis, Familial,Endocrine Adenomatosis, Multiple,Endocrine Adenopathies, Multiple,Endocrine Adenopathy, Multiple,Endocrine Neoplasms, Multiple,Familial Endocrine Adenomatoses,Multiple Endocrine Adenomatoses,Multiple Endocrine Adenopathies
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas

Related Publications

J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
September 1985, Presse medicale (Paris, France : 1983),
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
June 1986, Endocrinologia japonica,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
December 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
December 1985, Nuklearmedizin. Nuclear medicine,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
January 1989, Henry Ford Hospital medical journal,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
January 1991, Medical oncology and tumor pharmacotherapy,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
September 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
January 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
January 2015, Journal of labelled compounds & radiopharmaceuticals,
J L Baulieu, and D Guilloteau, and M J Delisle, and R Perdrisot, and P Gardet, and N Delépine, and F Baulieu, and J L Dupont, and J N Talbot, and G Coutris
June 1993, European journal of nuclear medicine,
Copied contents to your clipboard!